Human DNA adduct measurements: State of the art

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 5, 1996, Pages 883-893

  Poirier, Miriam C ^a   Weston, Ainsley ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

32P postlabeling; Ambient benzo a pyrene; Biomarkers; Enzyme linked immunosorbent assay; Fluorescence spectroscopy; Gas chromatography mass spectrometry; Occupational exposure; Polycyclic aromatic hydrocarbons

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATIC AMINE; BENZO[A]PYRENE; BIOLOGICAL MARKER; CARCINOGEN; HETEROCYCLIC AMINE; MYCOTOXIN; NITROSAMINE; PHOSPHORUS 32; POLYCYCLIC AROMATIC HYDROCARBON;

BLOOD CELL; CANCER; CONFERENCE PAPER; DNA ADDUCT; DOSIMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE SPECTROSCOPY; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; MEASUREMENT; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

EID: 0029800844     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104s5883     Document Type: Conference Paper

References (156)

1. Yuspa SH, Poirier MC. Chemical carcinogenesis: from animal models to molecular models in one decade. Adv Cancer Res 50:25-70 (1988).
2. Beland FA, Poirier MC. DNA adduces and carcinogenesis. In: Pathobiology of Neoplasia (Sirica AE, ed). New York:Plenum Press, 1989;57-80.
3. Wogan GN. Markers of exposure to carcinogens. Environ Health Perspect 81:9-17 (1989).
4. Poirier MC, Beland FA. DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: implications for DNA adduct-based human cancer risk assessment. Chem Res Toxicol 5:749-755 (1992).
5. Poirier MC, Gupta-Burt S, Litterst CL, Reed E. Detection of cisplatin-DNA adducts in humans. In: Immunoassays for Monitoring Human Exposure to Toxic Chemicals. (Vanderlaan M, ed). Washington:American Chemical Society; 300-307.
6. Terheggen PM, Dijkman R, Begg AC, Dubbelman R, Floot BG, Hart AA, den Engelse L. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutane-dicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients. Cancer Res 48:5597-5603 (1988).
7. 1-DNA adducts formed in vivo. Cancer Res 48:6328-6331 (1988).
8. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7:1543-1551 (1986).
9. 32P-postlabeling assay. Carcinogenesis 13:1053-1074 (1992).
10. Weston A, Bowman ED, Manchester DK, Harris CC. Fluorescence detection of lesions in DNA. In: DNA Damage and Repair in Human Tissues (Sutherland BM, Woodhead AD, eds). New York:Plenum Press; 1990;63-81.
11. Shuker DEG, Prevost V, Friesen MD, Lin D, Ohshima H, Bartsch H. Urinary markers for measuring exposure to endogenous and exogenous alkylating agents and precursors. Environ Health Perspect 99:33-37 (1993).
12. Reed E, Sauerhoff S, Poirier MC. Quantitation of platinum-DNA binding after therapeutic levels of drug exposure. Atomic Spectroscopy 9:93-95 (1988).
13. Reed E, Ozols RF, Tarone R, Yuspa SH, Poirier MC. The measurement of cisplatin-DNA adduct levels in testicular cancer patients. Carcinogenesis 9:1909-1911 (1988).
14. Floyd RA, Watson JJ, Wong PK, Altmiller DH, Rickard RC. Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation. Free Radic Res Commun 1:63-172 (1993).
15. Poirier, MC. Antibodies to carcinogen-DNA adducts. J Natl Cancer Inst 67:515-519 (1981).
16. Poirier MC. The use of carcinogen-DNA adduct antisera for quantitation and localization of genomic damage in animal models and the human population. Environ Mol Mutagen 6:879-887 (1984).
17. 6-ethyldeoxyguanosine in DNA exposed to the carcinogen ethylnitrosourea in vivo or in vitro. Z Naturforsch 33:897-901 (1978).
18. 2-acetylaminofluorene. FEBS Lett 92:207-210 (1978).
19. Strickland PT, Boyle JM. Immunoassay of carcinogen-modified DNA. Prog Nucleic Acid Res Mol Biol 31:1-58 (1984).
20. Phillips DH. Modern methods of DNA adduct determination. In: Handbook of Experimental Pharmacology. Vol 94:I (Cooper CS, Grover PL, eds). Berlin:Springer-Verlag, 1990;503-546.
21. Santella RM, Yang XY, Hsieh LL, Young TL. Immunologic methods for the detection of carcinogen adducts in humans. Prog Clin Biol Res 340C:247-257 (1990).
22. Poirier MC, Yuspa SH, Weinstein IB, Blobstein S. Detection of carcinogen-DNA adducts by radioimmunoassay. Nature 270:186-188 (1977).
23. Poirier MC, Weston A. DNA adduct determination in humans. Prog Clin Biol Res 372:205-218 (1991).
24. Santella RM, Hsieh LL, Lin CD, Viet S, Weinstein IB. Quantitation of exposure to benzo[a]pyrene with monoclonal antibodies. Environ Health Perspect 62:95-99 (1985).
25. Poirier MC. Development of Immunoassays for the Detection of Carcinogen-DNA Adducts. In: Molecular Dosimetry and Human Cancer (Skipper PL, Groopman JD, eds). Boca Raton, FL:CRC Press 1991;211-229.
26. Poirier MC. Immunochemical methods for assaying carcinogen-DNA adducts. In: Human Carcinogen Exposure (Garner RC, Farmer PB, Steel GT, Wright AS, eds). Oxford:Oxford University Press, 1991;69-83.
27. 1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report. Gastroenterology 97:1281-1287 (1989).
28. Groopman JD, Donahue PR, Zhu JQ, Chen JS, Wogan GN. Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. Proc Natl Acad Sci USA 82:6492-6496 (1985).
29. Sun TT, Wu SM, Wu YY, Chu Y. Measurement of individual aflatoxin exposure among people having different risk to primary hepatocellular carcinoma. In: Diet, Nutrition and Cancer (Hyaishi Y, Nagao M, Sugimura T, Takayama S, Tomatis L, Wattenberg W, Wogan GN, eds). Tokyo:Japan Scientific Society Press 1986;225-235.
30. Talaska G, al-Juburi AZ, Kadlubar FF. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci USA 88:5350-5354 (1991).
31. Roberts DW, Benson RW, Groopman JD, Flammang TJ, Nagle WA, Moss AJ, Kadlubar FF. Immunochemical quantitation of DNA adducts derived from the human bladder carcinogen 4-aminobiphenyl. Cancer Res 48:6336-6342 (1988).
32. 6-Methyldeoxyguanosine in oesophageal DNA among individuals at high risk of oesophageal cancer. Int J Cancer 36: 661-665 (1985).
33. 4-etnylthymine in liver DNA of individuals with or without malignant tumors. Cancer Res 49:93-97 (1989).
34. 6-alkylguanine-DNA alkyltransferase activities in gastric mucosa and circulating lymphocytes. Carcinogenesis 11:431-436 (1990).
35. Haugen A, Becher G, Benestad C, Vahakangas K, Trivers GE, Newman MJ, Harris CC. Determination of polycyclic aromatic hydrocarbons in the urine, benzo[a]pyrene diol epoxide-DNA adducts in lymphocyte DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere. Cancer Res 46:4178-4183 (1986).
36. van Schooten FJ, Hillebrand MJ, van Leeuwen FE, Lutgerink JT, van Zandwijk N, Jansen HM, Kriek E. Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients. Carcinogenesis 11:1677-1681 (1990).
37. Perera FP, Hemminki K, Young TL, Brenner D, Kelly G, Santella RM. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers. Cancer Res 48:2288-2291 (1988).
38. Poirier MC, Egorin MJ, Fichtinger-Schepman AM, Yuspa SH, Reed E. DNA adducts of cisplatin and carboplatin in tissues of cancer patients. IARC Sci Publ 313-320 (1988).
39. 6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair. Cancer Res 50:2759-2764 (1990).
40. 7-methylguanine in DNA of white blood cells from cancer patients treated with dacarbazine. Carcinogenesis 13:1257-1259 (1992).
41. Santella RM, Hemminki K, Tang DL, Paik M, Ottman R, Young TL, Savela K, Vodickova L, Dickey C, Whyatt R, Perera FP. Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells and urinary 1-hydroxypyrene in foundry workers. Cancer Epidemiol Biom Prev 2:59-62 (1993).
42. Santella RM, Yang XY, DeLeo VA, Gasparro FP. Detection and quantification of 8-methoxypsoralen-DNA adducts. In: Methods for Detecting DNA Damaging Agents in Humans Applications in Cancer Epidemiology and Prevention. Vol 89 (Bartsch H, Hemminki K, O'Neill IK, eds). Lyon:International Agency for Research on Cancer, 1988;333-340.
43. Degan P, Shigenaga MK, Park EM, Alperin PE, Ames BN. Immunoaffinity isolation of urinary 8-hydroxy-2′-deoxyguanosine and 8-hydroxyguanine and quantitation of 8-hydroxy-2′-deoxyguanosine in DNA by polyclonal antibodies. Carcinogenesis 12:865-871 (1991).
44. Bruze M, Emmett EA, Creasey J, Strickland PT. Cyclobutadithymidine induction by solar-simulating UV radiation in human skin. II: Individual responses. J Invest Dermatol 93:341-344 (1989).
45. Terheggen PMAB, Begg AC, Emondt JY, Dubbelman R, Floot BGJ, den Engelse L. Formation of interaction products of carboplatin with DNA in vitro and in cancer patients. Br J Cancer 63:195-200 (1991).
46. Yang XY, DeLeo V, Santella, RM. Immunological detection and visualization of 8-methoxypsoralen-DNA photoadducts. Cancer Res 47:2451-2455 (1987).
47. Yang XY, Gasparro FP, DeLeo VA, Santella RM. 8-Methoxypsoralen-DNA adducts in patients treated with 8-methoxypsoralen and ultraviolet A light. J Invest Dermatol 92:59-63 (1989).
48. Roza L, De Gruijl FR, Bergen Henegouwen JB, Guikers K, Van Weelden H, Van Der Schans GP, Baan RA. Detection of photorepair of UV-induced thymine dimers in human epidermis by immunofluorescence microscopy. J Invest Dermatol 96:903-907 (1991).
49. Weston A. Physical methods for the detection of carcinogen-DNA adducts in humans. Mutat Res 288:19-29 (1993).
50. 32P-postlabeling, and immunoprecipitation. Cancer Res 52:5307-5312 (1992).
51. 32P-postlabeling assay. Carcinogenesis 14:545-550 (1993).
52. Cuzick J, Routledge MN, Jenkins D, Garner RC. DNA adducts in different tissues of smokers and nonsmokers. Int J Cancer 45:673-678 (1990).
53. 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers. Carcinogenesis 12:1301-1305 (1991).
54. Hemminki K, Perera FP, Phillips DH, Randerath K, Reddy, MV, Santella RM. Aromatic deoxyribonucleic acid adducts in white blood cells of foundry and coke oven workers. Scand J Work Environ Health 14(Suppl 1):55-56 (1988).
55. Hemminki K, Perera FP, Phillips DH, Randerath K, Reddy MV, Santella RM. Aromatic DNA adducts in white blood cells of foundry workers. IARC Sci Publ 89:190-195 (1988).
56. Perera FP, Hemminki K, Gryzbowska E, Motykiewicz G, Michalska J, Santella RM, Young TL, Dickey C, Brandt-Rauf, DeVivo P, Blaner I, Tsai WY, Chorazy M. Molecular and genetic damage in humans from environmental pollution in Poland. Nature 360:256-258 (1992).
57. 32P-postlabeling assay of N7-methyldeoxyguanosine. Cancer Res 50:6580-6584 (1990).
58. 32P-postlabeling assay for polycyclic aromatic hydrocarbon DNA adducts. Mutagenesis 8:121-126 (1993).
59. 32P-postlabeling assay. Mutat Res 288:5-18 (1993).
60. 32P-postlabeled DNA adducts. Carcinogenesis 14:1343-1348 (1993).
61. Weston A, Bowman ED. Fluorescence detection of benzo[a]-pyrene-DNA adducts in human lung. Carcinogenesis 12:1445-1449 (1991).
62. Weston A, Bowman ED, Shields PG, Trivers GE, Poirier MC, Santella RM, Manchester DK. Detection of polycyclic aromatic hydrocarbon-DNA adducts in human lung. Environ Health Perspect 99:257-259 (1993).
63. 1, its metabolites, and DNA adducts by synchronous fluorescence spectrophotometry. Cancer Res 46:3249-3253 (1986).
64. Vahakangas K, Haugen A, Harris CC. An applied synchronous fluorescence spectrophotometric assay to study benzo[a]pyrene-diolepoxide-DNA adducts. Carcinogenesis 6:1109-1115 (1985).
65. Harris CC, Vahakangas K, Newman MJ, Trivers GE, Shamsuddin A, Sinopoli N, Mann DL, Wright WE. Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci USA 82:6672-6676 (1985).
66. Weston A, Rowe ML, Manchester DK, Farmer PB, Mann DL, Harris CC. Fluorescence and mass spectral evidence for the formation of benzo[a]pyrene anti-diol-epoxide-DNA and -hemoglobin adducts in humans. Carcinogenesis 10:251-257 (1989).
67. Corley J, Hurtubisem RJ, Bowman ED, Weston A. Solid matrix, room temperature phosphorescence identification and quantitation of the tetrahydrocetrols derived from the acid hydrolysis of benzo[a]pyrene-DNA adducts from human lung. Carcinogenesis 16:423-426 (1995).
68. Corley JS, Hurtubise RJ. Luminescence properties and analytical figures of merit of the tetrols of benzo[a]pyrene-DNA adducts adsorbed on α-, β- and τ- cyclodextrin/NaCl mixtures [Abstract]. Anal Lett 25:1559-1572 (1993).
69. Groopman JD, Sabbioni G, Wild CP. Molecular dosimetry of human aflatoxin exposures. In: Molecular Dosimetry and Human Cancer (Groopman JD, ed). Boca Raton, FL:CRC Press. 1991:303-324.
70. Herron DC, Shank RC. Methylated purines in human liver DNA after probable dimethylnitrosamine poisoning. Cancer Res 40:3116-3117 (1993).
71. Watson WP, Smith RJ, Huckle KR, Wright AS. Comparison of hydrocarbon DNA adducts formed in mouse and human skin following treatment with benzo[a]pyrene. Arch Toxicol (Suppl 11):93-98 (1987).
72. Farmer PB, Shukern EG, Bird I. DNA and protein adducts as indicators of in vivo methylation by nitrosatable drugs. Carcinogenesis 7:9-52 (1986).
73. Farmer PB, Bailey E, Green JA, Leung CS, Manson MM. Biomonitoring of human exposure to alkylating agents by measurement of adducts to haemoglobin or DNA. IARC Sci Publ 109:71-77 (1991).
74. Bryant MS, Skipper PL, Tannenbaum SR, Maclure, M. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res 47:602-608 (1987).
75. Bryant MS, Vineis P, Skipper PL, Tannenbaum SR. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc Natl Acad Sci USA 85:9788-9791 (1988).
76. Hecht SS, Haley NJ, Hoffman D. Monitoring exposure to tobacco products by measurement of nicotine metabolites and derived carcinogens. In: Molecular Dosimetry and Human Cancer (Groopman JD, ed). Boca Raton, FL:CRC Press, 1991;325-361.
77. Shuker DE. Nucleic acid-carcinogen adducts in human dosimetry. Arch Toxicol Suppl 13:55-65 (1989).
78. Farmer PB. Analytical approaches for the determination of protein-carcinogen adducts using mass spectrometry. In: Molecular Dosimetry and Human Cancer (JD Groopman, ed). Boca Raton, FL:CRC Press, 1991;189-210.
79. Stillwell WG, Glogowski J, Xu HX, Wishnok JS, Zavala D, Montes G, Correa P, Tannenbaum SR. Urinary excretion of nitrate, N-nitrosoproline, 3-methyladenine, and 7-methylguanine in a Colombian population at high risk for stomach cancer. Cancer Res 51:190-194 (1991).
80. Prevost V, Shuker DE, Friesen MD, Eberle G, Rajewsky MF, Bartsch H. Immunoaffinity purification and gas chromatography-mass spectrometric quantification of 3-alkyladenines in urine: metabolism studies and basal excretion levels in man. Carcinogenesis 14:199-204 (1993).
81. Foiles PG, Akerkar SA, Carmella SG, Kagan M, Stoner GD, Resau JH, Hecht SS. Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem Res Toxicol 4:364-368 (1991).
82. Manchester, DK, Weston A, Choi JS, Trivers GE, Fennessey PV, Quintana E, Farmer PB, Mann DL, Harris CC. Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. Proc Natl Acad Sci USA 85:9243-9247 (1988).
83. Lin D, Lay JO, Bryant MS, Malaveille C, Friesen M, Bartsch H, Lang NP, Kadlubar FF. Analysis of 4-aminobiphenyl-DNA in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. Environ Health Perspect 102:11-16 (1993).
84. 32P-postlabeling. Chem Res Toxicol 7:733-739 (1994).
85. Fichtinger-Schepman AMJ, van der Velde-Visser SD, van Dijk-Knijnenburg HCM, van Oosterom AT, Baan RA, Berends F. Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation. Cancer Res 50:7887-7894 (1990).
86. Poirier MC, Reed E, Litterst CL, Katz D, Gupta-Burt S. Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients. Cancer Res 52:149-153 (1992).
87. Plooy AC, Fichtinger-Schepman AM, Schutte HH, van Dijk M, Lohman PH. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques. Carcinogenesis 6:561-566 (1985).
88. Reed E, Gupta-Burt S, Litterst CL, Poirier MC. Characterization of the DNA damage recognized by an anti-serum elicited against cis-diamminedichloroplatinum (II)-modified DNA. Carcinogenesis 11:2117-2121 (1990).
89. Dahman EAMF. Introduction. In: Electroanalysis: Theory and Applications in Aqueous and Non-aqueous Media and in Automated Chemical Control. Amsterdam:Elsevier, 1986;3-9.
90. Stulik K, Pacakova V. Selected applications of electrochemical detectors in flowing liquids. In: Electroanalytical Measurements in Flowing Liquids (Chalmers RA, Masson M, Miller JN, eds). Chichester, U.K.:Ellis Horwood, 1987;11-26.
91. Stulik K, Pacakova V. Selected applications of electrochemical detectors in flowing liquids. In: Electroanalytical Measurements in Flowing Liquids (Chalmers RA, Masson M, eds). Chichester, U.K.:Ellis Horwood, 1987:204-279.
92. Kasai H, Crain PF, Kuchino Y, Nishimura S, Ootsuyama A, Tanooka H. Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis 7:1849-1851 (1986).
93. Shigenaga MK, Gimeno CJ, Ames BN. Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA 86:9697-9701 (1989).
94. Kiyosawa H, Suko M, Okudaira H, Murata K, Miyamoto T, Chung MH, Kasai H, Nishimura S. Cigarette smoking induces formation of 8-hydroxydeoxyguanosine, one of the oxidative DNA damages in human peripheral leukocytes. Free Radic Res Commun 11:23-27 (1990).
95. 32P-postlabeling and nucleotide chromatographic analysis. Cancer Res 48:2156-2161 (1988).
96. Santella RM, Weston A, Perera FP, Trivers GT, Harris CC, Young TL, Neuyen D, Lee BM, Poirier MC. Interlaboratory comparison of antisera and immunoassays for benzo[a]pyrene-diol-epoxide-I-modified DNA. Carcinogenesis 9:1265-1269 (1988).
97. Weston A, Beland FA, Manchester DK, Parker NB, Harris CC, Poirier MC. Development of preparative immunoaffinity chromatography for the isolation of aromatic amine-DNA adducts from humans. Proc Am Assoc Cancer Res 30:134 (1989).
98. Weston A, Manchester DK, Poirier MC, Choi JS, Trivers GE, Mann DL, Harris CC. Derivative fluorescence spectral analysis of polycyclic aromatic hydrocarbon-DNA adducts in human placenta. Chem Res Toxicol 2:104-108 (1989).
99. 32P-postlabeling analysis of human placental DNA known to contain benzo[a]pyrene diol epoxide adducts. Carcinogenesis 11:553-559 (1990).
100. Shields PG, Bowman ED, Harrington AM, Doan VT, Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res 53:3486-3492 (1993).
101. Bianchini F, Montesano R, Shuker DEG, Cuzick J, Wild CP. Quantification of 7-methyldeoxyguanosine using immunoaffinity purification and HPLC with electrochemical detection. Carcinogenesis 14:1677-1682 (1993).
102. Groopman JD, Hasler JA, Trudel LJ, Pikul A, Donahue PR, Wogan GN. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity-high performance liquid chromatography. Cancer Res 52:267-274 (1992).
103. Groopman JD, Zhu JQ, Donahue PR, Pikul A, Zhang LS, Chen JS, Wogan GN. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Cancer Res 52:45-52 (1992).
104. 6-methylguanine in DNA from human tissues. Carcinogenesis 13:469-475 (1992).
105. Hemminki K, Randerath K, Reddy MV, Putman KL, Santella RM, Perera F, Young TL, Phillips DH, Hewer A, Savela K. Postlabeling and immunoassay analysis of polycyclic aromatic hydrocarbons-adducts of deoxyribonucleic acid in white blood cells of foundry workers. Scand J Work Environ Health 16:158-162 (1990).
106. Poirier MC, Schoket B, Weston A, Rothman N, Scott B, Deeter DP. Blood cell polycyclic aromatic hydrocarbon (PAH)-DNA adducts and PAH urinary metabolites in soldiers exposed to Kuwaiti oil well fires. Proc Am Assoc Cancer Res 35:569:95 (1994).
107. Grzybowska E, Hemminki K, Szeliga J, Chorazy M. Seasonal variation of aromatic DNA adducts in human lymphocytes and granulocytes. Carcinogenesis 14:2523-2526 (1993).
108. Mumford JL, Lee X, Lewtas J, Young TL, Santella RM. DNA adducts as biomarkers for assessing exposure to polycyclic aromatic hydrocarbons in tissues from Xuan Wei women with high exposure to coal combustion emissions and high lung cancer mortality. Environ Health Perspect 99:83-87 (1993).
109. van Schooten FJ, van Leeuwen FE, Hillebrand MJ, de Rijke ME, Hart AA, van Veen HG, Oosterink S, Kriek E. Determination of benzo[a]pyrene diol epoxide-DNA adducts in white blood cell DNA from coke-oven workers: the impact of smoking. J Natl Cancer Inst 82: 927-933 (1990).
110. Hemminki K, Grzybowska E, Chorazy M, Twardowska-Saucha K, Sroczynski JW, Putman KL, Randerath K, Phillips DH, Hewer A, Santella RM, Young TLI, Perera FP. DNA adducts in human environmentally exposed to aromatic compounds in an industrial area of Poland. Carcinogenesis 11:1229-1231 (1990).
111. Poirier MC, Santella R, Weinstein IB, Grunberger D, Yuspa S. Quantitation of benzo[a]pyrene-deoxyguanosine adducts by radioimmunoassay. Cancer Res 40:412-416 (1980).
112. Schoket B, Doty WA, Vincze I, Strickland PT, Assennato G, Poirier MC. Increased sensitivity for determination of polycyclic aromatic hydrocarbon-DNA adducts in human DNA samples by dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA). Cancer Epidemiol Biomark Prev 2:349-353 (1993).
113. Rothman N, Correa-Villasenor A, Ford DP, Poirier MC, Haas R, Hansen JA, O'Toole T, Strickland PT. Contribution of occupation and diet to white blood cell polycyclic aromatic hydrocarbon-DNA adducts in wildland firefighters. Cancer Epidemiol Biomark Prev 2:341-348 (1993).
114. Groopman JD, Trudel LJ, Donahue PR, Marshak-Rothstein A, Wogan GN. High-affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays. Proc Natl Acad Sci USA 81:7728-7731 (1984).
115. Poirier MC, Reed E, Zwelling LA, Ozols RF, Litterst CL, Yuspa SH. The use of polyclonal antibodies to quantitate cis-diamminedichloropladum (II)-DNA adducts in cancer patients and animal models. Environ Health Perspect 62:89-94 (1985).
116. Reed E, Yuspa SH, Zwelling LA, Ozols RF, Poirier MC. Quantitation of cisplatin-DNA intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy. J Clin Invest 77:545-550 (1986).
117. 6-methylguanine in human DNA after therapeutic exposure to methylating agents and its relationship with biological effects. Environ Health Perspect 99:143-147 (1993).
118. Poirier MC. Human DNA adduct determinations: Applications in clinical treatment. In: Therapeutic Aspects and Analytical Methods in Cancer Research (Constantin E, ed). Strasbourg, France:Amudes Publications, 1994;19-35.
119. Alexandrov K, Rojas M, Geneste O, Castegnaro M, Camus AM, Petruzzelli S, Giuntini C, Bartsch H. An improved fluorometric assay for dosimetry of benzo[a]pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon nydroxylase activity. Cancer Res 52:6248-6253 (1992).
120. Santella RM, Perera, FP, Young TL, Zhang YJ, Chiamprasert S, Tang D, Wang LW, Beachman A, Lin JH, DeLeo VA. Polycyclic aromatic hydrocarbon-DNA and protein adducts in coal tar treated patients and controls and their relationship to glutathione S-transferase genotype. Mutat Res 334:117-124 (1995).
121. Jongeneelen FJ. Biological monitoring of environmental exposure to polycyclic aromatic hydrocarbons; 1-hydroxypyrene in urine of people. Toxicol Lett 72:205-211 (1994).
122. VanRooij JG, Bodelier-Bade MM, Hopmans PM, Jongeneelen FJ. Reduction of urinary 1-hydroxypyrene excretion in coke-oven workers exposed to polycyclic aromatic hydrocarbons due to improved hygienic skin protective measures. Ann Occup Hyg 38:247-256 (1994).
123. Weston A, Bowman ED, Carr P, Rothman N, Strickland PT. Detection of metabolites of polycyclic aromatic hydrocarbons in human urine. Carcinogenesis 14:1053-1055 (1993).
124. Strickland PT, Kang D, Bowman ED, Fitzwilliam A, Downing TE, Rothman N, Groopman JD, Weston A. Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. Carcinogenesis 15:483-487 (1994).
125. Day BW, Naylor S, Gan LS, Sahali Y, Nguyen TT, Skipper PL, Wishnok JS, Tannenbaum SR. Molecular dosimetry of polycyclic aromatic hydrocarbon epoxides and diol epoxides via hemoglobin adducts. Cancer Res 50:4611-4618 (1990).
126. Melikian AA, Sun P, Amin S, Hecht SS. Gas chromatography-mass spectrometry (GC-MS) characterization of polycyclic aromatic hydrocarbon (PAH)-derived globin adducts in smokers. Proc Am Assoc Cancer Res 36:667:112 (1995).
127. Ferreira MF Jr, Tas S, dell'Omo M, Goormans G, Buchet JP Lauwerys R. Determinants of benzo[a]pyrenediol epoxide adducts to haemoglobin in workers exposed to polycyclic aromatic hydrocarbons. Occup Environ Med 51:451-455 (1994).
128. Perera FP, Tang DL, O'Neill JP, Bigbee WL, Albertini RJ, Santella R, Ottman R, Tsai WY, Dickey C, Mooney LA. HPRT and glycophorin A mutations in foundry workers: relationship to PAH exposure and to PAH-DNA adducts. Carcinogenesis 14:969-973 (1993).
129. Perera FP, Dickey C, Santella R, O'Neill JP, Albertini RJ, Ottman R, Tsai WY, Mooney LA, Savela K, Hemminki K. Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. Carcinogenesis 15:2905-2910 (1994).
130. Wilson VL, Weston A, Manchester DK, Trivers GE, Roberts DW, Kadlubar FF, Wild CP, Montesano R, Willey JC, Mann, DL, Harris CC. Alkyl and aryl carcinogen adducts detected in human peripheral lung. Carcinogenesis 10:2149-2153 (1989).
131. Fichtinger-Schepman AM, van Oosterom AT, Lohman PH, Berends F. cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II). Cancer Res 47:3000-3004 (1987).
132. Rothman N, Poirier MC, Baser ME, Hansen JA, Gentile C, Bowman ED, Strickland PT. Formation of polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells during consumption of charcoal-broiled beef. Carcinogenesis 11:1241-1243 (1990).
133. Schoket B, Horkay I, Kösa A, Paldeak L, Hewer A, Grover PL, Phillips DH. Formation of DNA adducts in the skin of psoriasis patients, in human skin in organ culture, and in mouse skin and lung following topical application of coal-tar and juniper tar. J Invest Dermatol 94:241-246 (1990).
134. 32P-postlabeling analysis. Mutat Res 202:85-91 (1988).
135. 32P-postlabeling. Cancer Epidemiol Biomark Prev 2:63-69 (1993).
136. Pfohl-Leszkowicz A, Grosse Y, Castegnaro M, Nicolov IG, Chernozemsky IN, Bartsch H, Betbeder AM, Creppy EE, Dirheimet G. Ochratoxin A-related DNA adducts in urinary tract tumours of Bulgarian subjects. In: Postlabeling Methods for Detection of DNA Adduct (Phillips DH, Castegnaro M, Bartsch H, eds). 1993;141-148.
137. Lewtas J, Mumford J, Everson RB, Hulka B, Wilcosky T, Kozumbo W, Thompson C, George M, Dobiäs L, Sram R. Comparison of DNA adduces from exposure to complex mixtures in various human tissues and experimental systems. Environ Health Perspect 99:89-97 (1993).
138. 32P-postlabeling and by enzyme-linked immunosorbent assay (ELISA). Environ Health Perspect 99:307-309 (1993).
139. 32P-postlabeling analysis. Carcinogenesis 11:205-211 (1990).
140. Bodell WJ, Pongracz K, Kaur S, Burlingame AL, Liu SF, Rappaport SM. Investigation of styrene oxide-DNA adducts and their detection in workers exposed to styrene. Prog Clin Biol Res 340C:271-282 (1990).
141. 32P-postlabeling. Carcinogenesis 15:1949-1953 (1994).
142. 32P-postlabeling detection of DNA adducts in mononuclear cells of workers occupationally exposed to styrene. Carcinogenesis 15:1309-1315 (1994).
143. 32P-postlabeling assay. Carcinogenesis 12:503-508 (1991).
144. 32P-postlabeling analysis of DNA adducts in monocytes of smokers and passive smokers. Int Arch Occup Environ Health 62:299-303 (1990).
145. Randerath K, Miller RH, Mittal D, Randerath E. Monitoring human exposure to carcinogens by ultrasensitive postlabeling assays: application to unidentified genotoxicants. IARC Sci Publ 89:361-367 (1988).
146. Phillips DH, Hewer A, Grover PL, Jass JR. An aromatic DNA adduct in colonic mucosa from patients with colorectal cancer. IARC Sci Publ 89:368-371 (1988).
147. Phillips DH, Hewer A, Grover PL. Aromatic DNA adducts in human bone marrow and peripheral blood leukocytes. Carcinogenesis 7:2071-2075 (1986).
148. 32P-postlabeling. Cancer Res 53:1522-1528 (1993).
149. 32P-postlabeling, in the foregut of patients with familial adenomatous polyposis and in unaffected controls. Carcinogenesis 12:1727-1732 (1991).
150. Groopman JD, Hall AJ, Whittle H, Hudson GJ, Wogan GN, Ruggero M, Wild CP. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in the Gambia, West Africa. Cancer Epidemiol Biomark Prev 1:221-227 (1992).
151. Weston A, Shields PG, Bowman ED. Isolation of polycyclic aromatic hydrocarbon-DNA adducts from human lung. In: Polycyclic Aromatic Compounds (Garrigues P, Lamotte M, eds). Bordeaux, France:Gordon and Breach Science Publishers, 1991:937.
152. Chaudhary AK, Nokubo M, Reddy GR, Yeola SN, Morrow JD, Blair IA, Marnett LJ. Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science 265:1580-1582 (1994).
153. Reed E, Parker RJ, Gill I, Bicher A, Dabholkar M, Vionnet JA, Bostick-Bruton F, Tarone R, Muggia FM. Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies. Cancer Res 53:3694-3699 (1993).
154. Anonymous. Tobacco smoking. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon:International Agency for Research on Cancer, 1986;83-126.
155. Ichiba M, Hagmar L, Rannug A, Hogstedt B, Alexandrie A-K, Carstensen U, Hemminki K. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis 15:1347-1352 (1994).
156. Rothman N, Shields P, Poirier MC, Harrington A, Ford DP, Strickland PT. The impact of glutathione S-transferase M1 and cytochrome P450 1A1 genotypes on white blood cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans. Mol Carcinogenesis 14:63-70 (1995).